To evaluate the impact of chronic inflammation on marginal zone B cells representation, we stained splenocytes from crt−/− FLC and mice with IBD with B220 together with CD21 and CD23 specific antibodies. The gene discussed is FCER2; the disease is inflammatory bowel disease.